Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product


Product Description
The Malvern m-VROCi utilizes unique microfluidic viscometer / rheometer on a chip technology to provide high resolution viscosity measurements into the ultra-high shear rate regime. High shear rate measurements for low viscosity materials are inaccessible with traditional mechanical rheometers, but are important and relevant conditions for many industrial processes and product use environments.

The m-VROCi uses a totally enclosed microfluidic slit flow system to deliver accurate and robust viscosity measurements for low viscosity materials to extreme shear rates, with ease of sample loading and operation

Narrow gap microscale flow channel with embedded MEMS pressure sensors enables a wide dynamic range in shear rate for added R&D capabilities
Extremely high shear rate measurements accessible due to operation in very low Reynolds Number regime well away from inertial flow instabilities
For low viscosity samples of the order of a few mPas, measurements at process-relevant shear rates in excess of 106s-1 are attainable
Rigorous flow channel corrections applied for non-Newtonian materials for full flow curve generation, enabling direct comparison of low shear rate data from a rotational rheometer
High resolution viscosity measurements enables reliable viscosity data with variations in formulation, particularly for low viscosity materials
Totally enclosed system enables accurate measurement of samples with volatile solvent bases – no evaporation
Small sample volumes can be used for cost effective viscosity measurements on early stage industrial formulations, and for high value chemical components
Ease of sample loading and operation with syringe-based system
Automated temperature control from 4ºC to 65ºC, including temperature sweeps
All wetted materials are highly chemically resistant
Product m-VROCi
Company Malvern Instruments Limited
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Malvern Instruments Limited
Grovewood Road Malvern Worcestershire WR14 1XZ UK

Tel: +44 (0) 1684 892456
Fax: +44 (0) 1684 892789

Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos